Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prop 65

This article was originally published in The Tan Sheet

Executive Summary

Three supplement ingredients - DHEA, androstenedione and Tribulus Terrestris - are challenged under California Proposition 65 by a group called Consumer Cause, represented by Los Angeles attorney Morse Mehrban. Consumer Cause charges the three ingredients expose consumers to "testosterone and its esters." In a June 27 letter to California Deputy Attorney General Ed Weil, NNFA and CRN say the notices of intent to sue are "invalid and should be retracted." The ingredients cannot expose consumers to testosterone as humans possess testosterone in their bodies naturally, the groups state, adding none of the ingredients contain testosterone. To date, the group has filed no lawsuits
Advertisement

Related Content

Smoking Cessation Patch, Gum Prop 65 Warning Federally Preempted - Court
Smoking Cessation Patch, Gum Prop 65 Warning Federally Preempted - Court
Smoking Cessation Patch, Gum Prop 65 Warning Federally Preempted - Court

Topics

Advertisement
UsernamePublicRestriction

Register

PS091521

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel